System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Prof Audrey Nosbaum is an expert in Dermatology at Centre Hospitalier Lyon Sud (France). As of September 2026, ScienceLeadR ranks Audrey Nosbaum in the top 1% of experts worldwide for Dermatitis, Hypersensitivity and Skin Diseases, Eczematous. Audrey Nosbaum has authored 335 publications, the most recent in 2026, and is an investigator in 15 clinical trials, 6 of them ongoing. SLR score: 1,229 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Audrey Nosbaum Centre Hospitalier Lyon Sud France
1 229 ScienceLeadR Reputation 1229

Unlock

Register Login
Network Map

Dermatology

Subspecialties: Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2007 - 2026
Source: PubMed

Claude Bernard University Lyon 1

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 335

Citations

Citations: 4 299 1st author: 33 Last author: 92 Unique author: 1

Main journals

Revue française d'allergologie 88
Eur J Dermatol 43
Ann Dermatol Venereol 28
Annales de dermatologie et de vénéréologie, FMC 18
J Eur Acad Dermatol Venereol 17

Best Journals

Cell 1
N Engl J Med 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Absolute Eczema Area and Severity Index Responses with Lebrikizumab in Patients with Moderate-to-severe Atopic Dermatitis: A Secondary Analysis of Two Phase 3 Trials.
PMID 42163822 — sexually transmitted diseases, dermatitis, eczema, immunoglobulin a, adolescent, dermatology, dermatitis, atopic, non-responder		Acta Derm Venereol20260
The definition of response and inadequate response to topical corticosteroid treatment in atopic dermatitis and related skin inflammatory diseases: A GA 2LEN ADCARE statement paper.
PMID 42028244 — skin, dermatitis, adrenal cortex hormones, therapeutics, dermatitis, atopic		World Allergy Organ J20260
Integrated Clinical Trial and Molecular Profiling Reveals Immune Drivers of Chronic Hand Eczema.
PMID 41705342 — skin, dermatitis, hypersensitivity, eczema, immunity, therapeutics, psoriasis, dermatitis, atopic, dermatitis, contact		Allergy20260
Eczema following IL-5 inhibitors for the treatment of severe asthma with improvement after switching to an IL-4Ra mAb.
PMID 41317962 — interleukin-5, hypersensitivity, eczema, therapeutics, asthma, dermatitis, atopic		J Allergy Clin Immunol Pract20250
[Dupilumab-associated head and neck dermatitis is associated with an overexpression of Interleukin 22].
PMID 41259704 — dermatitis		Med Sci (Paris)20250

Clinical Studies 15

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

N/A 6
Phase 3 5
Phase 2 3
Phase 4 1

By status:

Completed 7
Recruiting 3
Active not recruiting 2
Not yet recruiting 1
Terminated 1
Unknown 1

By type:

Interventional 12
Observational 3

By Monocentric/Multicentric:

monocentric 5
multicentric2to4 0
multicentric5to9 1
multicentricup10 9

Main Topics

Ongoing Clinical Trials

6 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Phase 3 Efficacy and Safety of Lebrikizumab in Adults With Nummular Eczema (LUMINE)
2025-522403-17-00 — safety, dermatitis, adrenal cortex hormones, eczema, therapeutics		Phase 3Recruiting2026
Study on an Investigational Yellow Fever Vaccine Compared with Stamaril in Adults in Europe and Asia
2022-502047-35-00 — yellow fever vaccine, antibody formation, safety, vaccines, yellow fever		Phase 2Active not recruiting2021
Dupilumab step down strategy to maintain remission in adult and adolescents patients with atopic dermatitis a non inferiority randomized trial
2022-501179-23-00 — dermatitis, adolescent, dermatitis, atopic		Phase 4Active not recruiting2023
Characterization of Visual Characteristics in Allergic Contact Dermatitis Using the Skincam Tool
NCT06351449 — skin, dermatitis, dermatitis, allergic contact, dermatitis, contact, patch tests		N/ANot yet recruiting2024
Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis
NCT06239311 — injections, skin, safety, dermatitis, pharmaceutical preparations, solutions, counterfeit drugs, therapeutics, methotrexate, dermatitis, atopic		Phase 3Recruiting2024

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS